235 related articles for article (PubMed ID: 29437913)
21. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
22. Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab.
Magro F; Lopes SI; Lopes J; Portela F; Cotter J; Lopes S; Moreira MJ; Lago P; Peixe P; Albuquerque A; Rodrigues S; Silva MR; Monteiro P; Lopes C; Monteiro L; Macedo G; Veloso L; Camila C; Afonso J; Geboes K; Carneiro F;
J Crohns Colitis; 2016 Dec; 10(12):1407-1416. PubMed ID: 27226417
[TBL] [Abstract][Full Text] [Related]
23. Real-life evaluation of histologic scores for Ulcerative Colitis in remission.
Arkteg CB; Wergeland Sørbye S; Buhl Riis L; Dalen SM; Florholmen J; Goll R
PLoS One; 2021; 16(3):e0248224. PubMed ID: 33684168
[TBL] [Abstract][Full Text] [Related]
24. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
[TBL] [Abstract][Full Text] [Related]
25. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of Faecal Immunochemical Test to Predict Endoscopic and Histological Healing in Ulcerative Colitis: A Prospective Study Based on Validated Histological Scores.
Shi HY; Chan FKL; Chan AWH; Higashimori A; Kyaw M; Ching JYL; Luk AKC; Wong SH; Wu JCY; Sung JJY; Ng SC
J Crohns Colitis; 2017 Sep; 11(9):1071-1077. PubMed ID: 28881876
[TBL] [Abstract][Full Text] [Related]
27. [Histological remission of ulcerative colitis with combined anti-cytokine and cell therapy].
Knyazev OV; Khomeriki SG; Kagramanova AV; Lishchinskaya AA; Smirnova OA; Noskova KK; Parfenov AI
Ter Arkh; 2021 Dec; 93(12):1435-1442. PubMed ID: 36286670
[TBL] [Abstract][Full Text] [Related]
28. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis.
Yamaguchi S; Takeuchi Y; Arai K; Fukuda K; Kuroki Y; Asonuma K; Takahashi H; Saruta M; Yoshida H
J Gastroenterol Hepatol; 2016 Jan; 31(1):93-8. PubMed ID: 26212346
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome.
Toyonaga T; Kobayashi T; Nakano M; Saito E; Umeda S; Okabayashi S; Ozaki R; Hibi T
PLoS One; 2017; 12(9):e0185131. PubMed ID: 28934315
[TBL] [Abstract][Full Text] [Related]
30. Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission.
Guardiola J; Lobatón T; Rodríguez-Alonso L; Ruiz-Cerulla A; Arajol C; Loayza C; Sanjuan X; Sánchez E; Rodríguez-Moranta F
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1865-70. PubMed ID: 24993368
[TBL] [Abstract][Full Text] [Related]
31. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
Buisson A; Vazeille E; Minet-Quinard R; Goutte M; Bouvier D; Goutorbe F; Pereira B; Barnich N; Bommelaer G
Aliment Pharmacol Ther; 2016 May; 43(10):1069-79. PubMed ID: 26953251
[TBL] [Abstract][Full Text] [Related]
32. Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectin.
Karling P; Lundgren D; Eklöf V; Palmqvist R; Hultdin J
Scand J Clin Lab Invest; 2019 Sep; 79(5):341-346. PubMed ID: 31164011
[TBL] [Abstract][Full Text] [Related]
33. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
[TBL] [Abstract][Full Text] [Related]
34. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis.
Shentova R; Baycheva M; Hadjiiski P; Kofinova D; Yaneva P
Gastroenterol Hepatol; 2020 Jan; 43(1):57-61. PubMed ID: 31733888
[TBL] [Abstract][Full Text] [Related]
35. Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis.
Guirgis M; Wendt E; Wang LM; Walsh A; Burger D; Bryant RV; Kent A; Adamson R; Brain O; Travis SPL; Keshav S
J Crohns Colitis; 2017 Apr; 11(4):460-467. PubMed ID: 27856523
[TBL] [Abstract][Full Text] [Related]
36. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374
[TBL] [Abstract][Full Text] [Related]
37. Composite Assessment Using Intestinal Ultrasound and Calprotectin Is Accurate in Predicting Histological Activity in Ulcerative Colitis: A Cohort Study.
Goodsall TM; Day AS; Andrews JM; Ruszkiewicz A; Ma C; Bryant RV
Inflamm Bowel Dis; 2024 Feb; 30(2):190-195. PubMed ID: 36928672
[TBL] [Abstract][Full Text] [Related]
38. Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission.
Garcia-Planella E; Mañosa M; Chaparro M; Beltrán B; Barreiro-de-Acosta M; Gordillo J; Ricart E; Bermejo F; García-Sánchez V; Piqueras M; Llaó J; Gisbert JP; Cabré E; Domènech E;
Scand J Gastroenterol; 2018 Feb; 53(2):152-157. PubMed ID: 29189092
[TBL] [Abstract][Full Text] [Related]
39. Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study.
Magro F; Lopes S; Silva M; Coelho R; Portela F; Branquinho D; Correia L; Fernandes S; Cravo M; Caldeira P; Sousa HT; Patita M; Lago P; Ramos J; Afonso J; Redondo I; Machado P; Cornillie F; Lopes J; Carneiro F;
J Crohns Colitis; 2019 Oct; 13(11):1387-1393. PubMed ID: 30989180
[TBL] [Abstract][Full Text] [Related]
40. Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis.
Theede K; Holck S; Ibsen P; Kallemose T; Nordgaard-Lassen I; Nielsen AM
Inflamm Bowel Dis; 2016 May; 22(5):1042-8. PubMed ID: 26919460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
